Growth Metrics

Twist Bioscience (TWST) Income from Continuing Operations: 2017-2025

Historic Income from Continuing Operations for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to -$77.7 million.

  • Twist Bioscience's Income from Continuing Operations rose 21.79% to -$27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.7 million, marking a year-over-year increase of 62.79%. This contributed to the annual value of -$77.7 million for FY2025, which is 62.80% up from last year.
  • As of FY2025, Twist Bioscience's Income from Continuing Operations stood at -$77.7 million, which was up 62.80% from -$208.8 million recorded in FY2024.
  • Twist Bioscience's 5-year Income from Continuing Operations high stood at -$77.7 million for FY2025, and its period low was -$217.9 million during FY2022.
  • Moreover, its 3-year median value for Income from Continuing Operations was -$204.7 million (2023), whereas its average is -$163.7 million.
  • Per our database at Business Quant, Twist Bioscience's Income from Continuing Operations crashed by 43.24% in 2022 and then skyrocketed by 62.80% in 2025.
  • Yearly analysis of 5 years shows Twist Bioscience's Income from Continuing Operations stood at -$152.1 million in 2021, then plummeted by 43.24% to -$217.9 million in 2022, then climbed by 6.06% to -$204.7 million in 2023, then fell by 2.00% to -$208.8 million in 2024, then skyrocketed by 62.80% to -$77.7 million in 2025.